The pharmacological management of patients with comorbid psoriasis and obesity.

Wendell C Valdecantos, Kristina Unnebrink, Ronald Prussick, Efficacy of Adalimumab Compared With Methotrexate or Placebo Stratified by Baseline BMI in a Randomized Placebo-Controlled Trial in Patients With Psoriasis. Journal of Drugs in Dermatology. ,vol. 14, pp. 864- 868 ,(2015)

DA Malatjalian, JB Ross, CN Williams, SJ Colwell, BJ Eastwood, Methotrexate hepatotoxicity in psoriatics: Report of 104 patients from Nova Scotia, with analysis of risks from obesity, diabetes and alcohol consumption during long term follow-up Canadian Journal of Gastroenterology & Hepatology. ,vol. 10, pp. 369- 375 ,(1996) , 10.1155/1996/213596

K.A. Papp, R.G. Langley, B. Sigurgeirsson, M. Abe, D.R. Baker, P. Konno, S. Haemmerle, H.J. Thurston, C. Papavassilis, H.B. Richards, Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study British Journal of Dermatology. ,vol. 168, pp. 412- 421 ,(2013) , 10.1111/BJD.12110

S Cazzaniga, S Chimenti, A Giannetti, M Maccarone, M Picardo, G Girolomoni, L Naldi, Psocare Study Group, None, Metabolic abnormalities associated with initiation of systemic treatment for psoriasis: evidence from the Italian Psocare Registry. Journal of The European Academy of Dermatology and Venereology. ,vol. 27, pp. 30- 41 ,(2013) , 10.1111/J.1468-3083.2012.04450.X

Monalyn Labitigan, Asena Bahče-Altuntas, Joel M. Kremer, George Reed, Jeff D. Greenberg, Nicole Jordan, Chaim Putterman, Anna Broder, Higher Rates and Clustering of Abnormal Lipids, Obesity, and Diabetes Mellitus in Psoriatic Arthritis Compared With Rheumatoid Arthritis Arthritis Care and Research. ,vol. 66, pp. 600- 607 ,(2014) , 10.1002/ACR.22185

Paolo Gisondi, Micol Del Giglio, Vincenzo Di Francesco, Mauro Zamboni, Giampiero Girolomoni, Weight loss improves the response of obese patients with moderate-to-severe chronic plaque psoriasis to low-dose cyclosporine therapy: a randomized, controlled, investigator-blinded clinical trial. The American Journal of Clinical Nutrition. ,vol. 88, pp. 1242- 1247 ,(2008) , 10.3945/AJCN.2008.26427

Eoin R. Storan, Josette Galligan, Louise Barnes, Phototherapy-induced erythema in patients with psoriasis and obesity treated with narrowband UVB phototherapy Photodermatology, Photoimmunology & Photomedicine. ,vol. 30, pp. 335- 337 ,(2014) , 10.1111/PHPP.12121

Kim Papp, Kristian Reich, Craig L. Leonardi, Leon Kircik, Sergio Chimenti, Richard G.B. Langley, ChiaChi Hu, Randall M. Stevens, Robert M. Day, Kenneth B. Gordon, Neil J. Korman, Christopher E.M. Griffiths, Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1) Journal of The American Academy of Dermatology. ,vol. 73, pp. 37- 49 ,(2015) , 10.1016/J.JAAD.2015.03.049

P. Gisondi, A. Conti, G. Galdo, S. Piaserico, C. De Simone, G. Girolomoni, Ustekinumab does not increase body mass index in patients with chronic plaque psoriasis: a prospective cohort study. British Journal of Dermatology. ,vol. 168, pp. 1124- 1127 ,(2013) , 10.1111/BJD.12235

A. Chiricozzi, M. Suárez‐Fariñas, J. Fuentes‐Duculan, I. Cueto, K. Li, S. Tian, C. Brodmerkel, J.G. Krueger, Increased expression of interleukin-17 pathway genes in nonlesional skin of moderate-to-severe psoriasis vulgaris. British Journal of Dermatology. ,vol. 174, pp. 136- 145 ,(2016) , 10.1111/BJD.14034